Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, USA.
D000275:Adjustment Disorders / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D002065:Buspirone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D013406:Suicide, Attempted / Q000517:prevention & control / Q000523:psychology*
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002065:Buspirone; D017374:Paroxetine; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors